Literature DB >> 1374544

Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype.

H Lefebvre1, V Contesse, C Delarue, M Feuilloley, F Hery, P Grise, G Raynaud, A A Verhofstad, L M Wolf, H Vaudry.   

Abstract

The occurrence of serotonin in the human adrenal gland was demonstrated both by immuno-histochemical and biochemical approaches. Using specific polyclonal antibodies to serotonin, the presence of numerous immunoreactive cells was revealed by means of the peroxidase-antiperoxidase technique. These cells exhibited the morphological characteristics of mast cells. Combination of high performance liquid chromatography and electrochemical detection showed the presence of substantial amounts of both serotonin and its metabolite 5-hydroxyindolacetic acid in adrenocortical extracts. The role of serotonin in the regulation of steroidogenesis from human adrenocortical slices was studied in vitro using a perifusion system technique coupled to a specific radioimmunoassay for cortisol. Graded doses of serotonin (from 10(-8) M to 3 x 10(-7) M) increased cortisol production in a dose-dependent manner. Prolonged exposure of adrenal fragments to serotonin (10(-7) M) induced a biphasic response, i.e. a rapid and transient increase in cortisol secretion followed by a plateau phase, suggesting the existence of a desensitization phenomenon. The stimulatory effect of serotonin (10(-7) M) was not altered during infusion of the serotonin1 and/or serotonin2 receptor antagonists methysergide (10(-6) M) and ketanserin (10(-6) M), respectively. In contrast, ICS 205 930 (10(-6) M), a non-selective serotonin3/serotonin4 antagonist, totally abolished the response of adrenal slices to serotonin (10(-7) M). The benzamide derivative zacopride, considered as a serotonin4 agonist, induced a robust stimulation of cortisol secretion. In addition, the corticotropic effects of serotonin (10(-7) M) and zacopride (10(-6) M) were not additive. Incubation of adrenocortical fragments with zacopride (10(-6) M) or serotonin (10(-6) M) caused a significant increase in cAMP formation. Taken together, these data suggest that serotonin, locally released by intra-adrenal mast-like cells, may act as a paracrine factor to stimulate cortisol secretion in man. Our results also indicate that serotonin-induced corticosteroid production is mediated through activation of a serotonin4 receptor subtype positively coupled to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374544     DOI: 10.1016/0306-4522(92)90047-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors.

Authors:  Peter M Szabó; Zoltán Wiener; Zsófia Tömböl; Attila Kovács; Péter Pócza; János Horányi; Janina Kulka; Peter Riesz; Miklós Tóth; Attila Patócs; Rolf C Gaillard; András Falus; Károly Rácz; Peter Igaz
Journal:  Virchows Arch       Date:  2009-07-01       Impact factor: 4.064

Review 3.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

4.  Role of cAMP/PKA pathway and T-type calcium channels in the mechanism of action of serotonin in human adrenocortical cells.

Authors:  Estelle Louiset; Céline Duparc; Sébastien Lenglet; Celso E Gomez-Sanchez; Hervé Lefebvre
Journal:  Mol Cell Endocrinol       Date:  2016-10-12       Impact factor: 4.102

5.  The guinea-pig distal colon--a sensitive preparation for the investigation of 5-HT4 receptor-mediated contractions.

Authors:  K A Wardle; G J Sanger
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Specific effects of escitalopram on neuroendocrine response.

Authors:  Emily R Hawken; James A Owen; Robert W Hudson; Nicholas J Delva
Journal:  Psychopharmacology (Berl)       Date:  2009-08-07       Impact factor: 4.530

7.  Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.

Authors:  Julie Le Mestre; Céline Duparc; Yves Reznik; Fidéline Bonnet-Serrano; Philippe Touraine; Olivier Chabre; Jacques Young; Mari Suzuki; Mathilde Sibony; Françoise Gobet; Constantine A Stratakis; Gérald Raverot; Jérôme Bertherat; Hervé Lefebvre; Estelle Louiset
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

8.  Serotonin increases interleukin-6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro.

Authors:  P K Ritchie; H H Knight; M Ashby; A M Judd
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

9.  PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Authors:  Zakariae Bram; Estelle Louiset; Bruno Ragazzon; Sylvie Renouf; Julien Wils; Céline Duparc; Isabelle Boutelet; Marthe Rizk-Rabin; Rossella Libé; Jacques Young; Dennis Carson; Marie-Christine Vantyghem; Eva Szarek; Antoine Martinez; Constantine A Stratakis; Jérôme Bertherat; Hervé Lefebvre
Journal:  JCI Insight       Date:  2016-09-22

10.  The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.

Authors:  Estelle Louiset; Constantine A Stratakis; Véronique Perraudin; Kurt J Griffin; Rossella Libé; Sylvie Cabrol; Bruno Fève; Jacques Young; Lionel Groussin; Jérôme Bertherat; Hervé Lefebvre
Journal:  J Clin Endocrinol Metab       Date:  2009-04-21       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.